許 準榕

研究成果

每年研究成果 1991 2003 2005 2011 2013 2014 2015 2017 2018 2023

• 285 文章
• 8 回顧型文獻
• 6 評論/辯論
• 3 社論
• 5 更多
  • 2 Erratum
  • 1 章節
  • 1 會議貢獻
  • 1 海报

每年研究成果

每年研究成果

搜尋結果

• 文章

  Lipoteichoic acid-induced cyclooxygenase-2 expression requires activations of p44/42 and p38 mitogen-activated protein kinase signal pathways

  Lin, C. H., Kuan, I. H., Wang, C. H., Lee, H. M., Lee, W. S., Sheu, J. R., Hsiao, G., Wu, C. H. & Kuo, H. P., 8月 16 2002, 於: European Journal of Pharmacology. 450, 1, p. 1-9 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • lipoteichoic acid 100%
  • Cyclooxygenase 2 72%
  • p38 Mitogen-Activated Protein Kinases 71%
  • SB 203580 57%
  • Genistein 54%
  21 引文 斯高帕斯（Scopus）

• Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: An intracellular study

  Chou, D. S., Hsiao, G., Shen, M. Y., Fong, T. H., Lin, C. H., Chen, T-F. & Sheu, J. R., 5月 2004, 於: Lipids. 39, 5, p. 433-440 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Low-Density Lipoprotein 100%
  • oxidized low density lipoprotein 86%
  • Blood Platelets 66%
  • In Vitro Techniques 37%
  • Platelet Aggregation 34%
  5 引文 斯高帕斯（Scopus）

• Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats

  Lee, Y. M., Hsiao, G., Chen, H. R., Chen, Y. C., Sheu, J. R. & Yen, M. H., 6月 22 2001, 於: European Journal of Pharmacology. 422, 1-3, p. 159-167 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • magnolol 100%
  • Myocardial Reperfusion Injury 77%
  • Reperfusion Injury 58%
  • Myocardial Ischemia 53%
  • Neutrophils 47%
  21 引文 斯高帕斯（Scopus）

• MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide

  Hsu, Y. F., Sheu, J. R., Lin, C-H., Chen, W. C., Hsiao, G., Ou, G., Chiu, P. T. & Hsu, M. J., 12月 2011, 於: Biochimica et Biophysica Acta - General Subjects. 1810, 12, p. 1160-1169 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Trichostatin A 100%
  • Dual Specificity Phosphatase 1 85%
  • trichostatin A 75%
  • Umbilicus 62%
  • Lipopolysaccharide 62%
  17 引文 斯高帕斯（Scopus）

• Mechamism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom

  Huang, T. F., Sheu, J. R. & Teng, C. M., 1991, 於: Thrombosis and Haemostasis. 66, 4, p. 489-493 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • triflavin 100%
  • Trimeresurus 85%
  • Snake Venoms 65%
  • Blood Platelets 38%
  • Peptides 31%
  4 引文 斯高帕斯（Scopus）

• Mechanism Involved in Methylene Blue-induced Tesion Changes in Isolated Guniea Pig Trachea

  Chou, D-S., Hsiao, G., Chen, T-F. & Sheu, J-R., 2001, 於: New Taipei Journal of Medicine. 3, 1, p. 18-25 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Mechanism involved in the antiplatelet activity of naloxone in human platelets

  Sheu, J. R., Hung, W. C., Lee, L. W., Chang, P. T., Kan, Y. C. & Yen, M. H., 2月 3 1997, 於: Biochemical and Biophysical Research Communications. 231, 1, p. 12-16 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Naloxone 100%
  • Anticoagulant Agent 91%
  • Blood Platelets 55%
  • triflavin 20%
  • Agonist 19%
  4 引文 斯高帕斯（Scopus）

• Mechanism of free radical generation in platelets and primary hepatocytes: A novel electron spin resonance study

  Wang, C. L., Yang, P. S., Tsao, J. T., Jayakumar, T., Wang, M. J., Sheu, J. R. & Chou, D. S., 1月 1 2018, 於: Molecular Medicine Reports. 17, 1, p. 2061-2069 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Electron Spin Resonance Spectroscopy 100%
  • Free Radicals 72%
  • Hepatocytes 64%
  • Free Radical 61%
  • Blood Platelets 60%
  1 引文 斯高帕斯（Scopus）

• Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa

  Sheu, J. R., Hung, W. C., Lee, Y. M. & Yen, M. H., 12月 30 1996, 於: European Journal of Pharmacology. 318, 2-3, p. 469-475 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Evodia 95%
  • Alkaloids 61%
  • Platelet Aggregation 56%
  • Platelet-Rich Plasma 21%
  • NG-Nitroarginine Methyl Ester 21%
  32 引文 斯高帕斯（Scopus）

• Mechanisms in the inhibition of neointimal hyperplasia with triflavin in a rat model of balloon angioplasty

  Sheu, J. R., Wu, C. H., Chen, Y. C., Hsiao, G. & Lin, C. H., 2001, 於: Journal of Laboratory and Clinical Medicine. 137, 4, p. 270-278 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • triflavin 100%
  • Balloon Angioplasty 58%
  • aggregation 52%
  • proliferation 44%
  • Hyperplasia 43%
  11 引文 斯高帕斯（Scopus）

• Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy

  Sheu, J. R., Hsiao, G., Lin, W. Y., Chen, T-F., Chien, Y. Y., Lin, C. H. & Tzeng, C. R., 2002, 於: Journal of Biomedical Science. 9, 1, p. 17-25 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Thromboxane A2 100%
  • Blood Platelets 53%
  • Prostaglandin E1 51%
  • Prostaglandin E2 46%
  • Pregnancy 41%
  10 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets

  Sheu, J. R., Hung, W. C., Kan, Y. C., Lee, Y. M. & Yen, M. H., 1998, 於: British Journal of Haematology. 103, 1, p. 29-38 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Lipopolysaccharides 100%
  • Blood Platelets 90%
  • Escherichia coli 81%
  • Cyclic GMP 24%
  • Platelet Aggregation 21%
  41 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of ketamine in human platelets

  Chang, Y., Chen, T. L., Wu, G. J., Hsiao, G., Shen, M. Y., Lin, K. H., Chou, D. S., Lin, C. H. & Sheu, J. R., 2004, 於: Journal of Biomedical Science. 11, 6, p. 764-772 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Ketamine 100%
  • Anticoagulant Agent 88%
  • Blood Platelets 53%
  • Platelet Aggregation 26%
  • Phosphoinositide 23%
  27 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of magnesium in human platelets

  Sheu, J. R., Hsiao, G., Shen, M. Y., Fong, T. H., Chen, Y. W., Lin, C. H. & Chou, D. S., 2002, 於: British Journal of Haematology. 119, 4, p. 1033-1041 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Magnesium Sulfate 100%
  • Magnesium 77%
  • Blood Platelets 59%
  • Thromboxane A2 19%
  • Collagen 17%
  39 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of midazolam in human platelets

  Sheu, J. R., Hsiao, G., Luk, H. N., Chen, Y. W., Chen, T. L., Lee, L. W., Lin, C-H. & Chou, D. S., 2002, 於: Anesthesiology. 96, 3, p. 651-658 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Midazolam 100%
  • Blood Platelets 69%
  • Thromboxanes 32%
  • Phosphatidylinositols 28%
  • Platelet Aggregation 26%
  17 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets

  Sheu, J. R., Hsiao, G., Chou, P. H., Shen, M. Y. & Chou, D. S., 7月 14 2004, 於: Journal of Agricultural and Food Chemistry. 52, 14, p. 4414-4418 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • 3-hydroxyflavone 100%
  • Rutin 90%
  • Flavonol 87%
  • Anticoagulant Agent 84%
  • Glycosides 79%
  123 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets

  Sheu, J. R., Lee, C. R., Lin, C. H., Hsiao, G., Ko, W-C., Chen, Y. C. & Yen, M. H., 2000, 於: Thrombosis and Haemostasis. 83, 5, p. 777-784 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • lipoteichoic acid 100%
  • Staphylococcus aureus 59%
  • Blood Platelets 53%
  • Thromboxane A2 24%
  • Phosphatidylinositols 20%
  71 引文 斯高帕斯（Scopus）

• Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets

  Sheu, J. R., Kan, Y. C., Hung, W. C., Ko, W. C. & Yen, M. H., 11月 1 1997, 於: Thrombosis Research. 88, 3, p. 259-270 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • tetramethylpyrazine 100%
  • Blood Platelets 51%
  • triflavin 26%
  • Platelet Glycoprotein GPIIb-IIIa Complex 24%
  • Collagen 20%
  55 引文 斯高帕斯（Scopus）

• Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty

  Wu, C. H., Chen, Y. C., Hsiao, G., Lin, C. H., Liu, C. M. & Sheu, J. R., 2月 1 2001, 於: Thrombosis Research. 101, 3, p. 127-138 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Abciximab 100%
  • Balloon Angioplasty 83%
  • Hyperplasia 62%
  • Integrins 33%
  • Angioplasty 27%
  18 引文 斯高帕斯（Scopus）

• Mechanisms of andrographolide-induced platelet apoptosis in human platelets: Regulatory roles of the extrinsic apoptotic pathway

  Lien, L-M., Su, C. C., Hsu, W. H., Lu, W-J., Chung, C-L., Yen, T. L., Chiu, H. C., Sheu, J-R. & Lin, K. H., 2013, 於: Phytotherapy Research. 27, 11, p. 1671-1677 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • andrographolide 100%
  • Blood Platelets 49%
  • Apoptosis 38%
  • Caspase 8 27%
  • Platelet Activation 17%
  27 引文 斯高帕斯（Scopus）

• Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies

  Hsiao, G., Shen, M. Y., Chou, D. S., Chang, Y., Lee, L. W., Lin, C-H. & Sheu, J. R., 3月 8 2004, 於: European Journal of Pharmacology. 487, 1-3, p. 159-166 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Midazolam 100%
  • In Vitro Techniques 38%
  • Thrombin 35%
  • Blood Platelets 34%
  • Phosphorylation 18%
  19 引文 斯高帕斯（Scopus）

• Mechanisms of ascorbyl radical formation in human platelet-rich plasma

  Shyu, K-G., Chang, C. C., Yeh, Y. C., Sheu, J. R. & Chou, D. S., 2014, 於: BioMed Research International. 2014, 614506.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • semidehydroascorbic acid 100%
  • Platelet-Rich Plasma 65%
  • Lipoxygenase 47%
  • NADPH Oxidases 42%
  • Enzyme Inhibitor 42%
  12 引文 斯高帕斯（Scopus）

• Mechanisms of resveratrol-induced platelet apoptosis

  Lin, K. H., Hsiao, G., Shih, C. M., Chou, D. S. & Sheu, J. R., 8月 2009, 於: Cardiovascular Research. 83, 3, p. 575-585 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Resveratrol 100%
  • Blood Platelets 66%
  • Apoptosis 52%
  • Platelet Aggregation 23%
  • Cytochromes c 16%
  94 引文 斯高帕斯（Scopus）

• Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling

  Hsia, C-H., Velusamy, M., Jayakumar, T., Chen, Y-J., Hsia, C-W., Tsai, J-H., Teng, R-D. & Sheu, J-R., 11月 19 2018, 於: Cells. 7, 11

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Ruthenium Compounds 100%
  • Macrophage Activation 60%
  • Lipopolysaccharide 57%
  • p38 Mitogen-Activated Protein Kinases 54%
  • Antiinflammatory 50%
  10 引文 斯高帕斯（Scopus）

• Modulation of biocompatibility on poly(vinylidene fluoride) and polysulfone by oxygen plasma treatment and dopamine coating

  Mangindaan, D., Yared, I., Kurniawan, H., Sheu, J. R. & Wang, M. J., 11月 2012, 於: Journal of Biomedical Materials Research - Part A. 100 A, 11, p. 3177-3188 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dopamine 100%
  • Polysulfones 99%
  • Biocompatibility 80%
  • Vinylidene Fluoride 73%
  • Poly(vinylidene) 71%
  26 引文 斯高帕斯（Scopus）

• Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: Regulation by integrin α_iIbβ₃ inside-out but not outside-in signals

  Hou, S. M., Hsia, C. W., Tsai, C. L., Hsia, C. H., Jayakumar, T., Velusamy, M. & Sheu, J. R., 5月 6 2020, 於: Journal of Biomedical Science. 27, 1, 60.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • columbianadin 100%
  • Platelet Activation 50%
  • Integrins 43%
  • Thrombosis 35%
  • Blood Vessels 27%
  13 引文 斯高帕斯（Scopus）

• Modulation of Monocyte-Derived Dendritic Cell Differentiation is Associated With Ischemic Acute Renal Failure

  Wu, C. J., Sheu, J. R., Chen, H. H., Liao, H. F., Yang, Y. C., Yang, S. & Chen, Y. J., 5月 2006, 於: Journal of Surgical Research. 132, 1, p. 104-111 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Acute Kidney Injury 100%
  • Dendritic Cells 94%
  • Monocytes 87%
  • Cell Differentiation 85%
  • Reperfusion 41%
  13 引文 斯高帕斯（Scopus）

• Morphine-potentiated agonist-induced platelet aggregation through α₂-adrenoceptors in human platelets

  Sheu, J. R., Yeh, G. C., Fang, C. L., Lin, C-H. & Hsiao, G., 11月 1 2002, 於: Journal of Cardiovascular Pharmacology. 40, 5, p. 743-750 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Platelet Aggregation 100%
  • Adrenergic Receptors 94%
  • Blood Platelets 77%
  • Yohimbine 36%
  • Collagen 30%
  14 引文 斯高帕斯（Scopus）

• Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments

  Hsiao, G., Shen, M. Y., Fang, C. L., Chou, D. S., Lin, C. H., Chen, T-F. & Sheu, J. R., 2003, 於: Journal of Biomedical Science. 10, 3, p. 292-301 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Morphine 100%
  • Platelet Aggregation 85%
  • Blood Platelets 65%
  • In Vitro Techniques 36%
  • Yohimbine 27%
  14 引文 斯高帕斯（Scopus）

• Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo

  Lien, L. M., Chen, Z. C., Chung, C. L., Yen, T. L., Chiu, H. C., Chou, D. S., Huang, S. Y., Sheu, J. R., Lu, W-J. & Lin, K. H., 8月 15 2014, 於: European Journal of Pharmacology. 737, p. 159-167 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Subfamily B ATP Binding Cassette Transporter 100%
  • Thrombosis 54%
  • Cyclic Nucleotides 42%
  • Platelet Activation 38%
  • leukotriene D4 receptor 35%
  21 引文 斯高帕斯（Scopus）

• Mycobacterium tuberculosis upregulates TNF-α Expression via TLR2/ERK signaling and induces MMP-1 and MMP-9 production in human pleural mesothelial cells

  Chen, W. L., Sheu, J. R., Chen, R. J., Hsiao, S. H., Hsiao, C. J., Chou, Y. C., Chung, C. L. & Hsiao, G., 9月 14 2015, 於: PLoS One. 10, 9, e0137979.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • interstitial collagenase 100%
  • gelatinase B 95%
  • tumor necrosis factors 88%
  • Matrix Metalloproteinase 1 81%
  • Mycobacterium tuberculosis 78%
  25 引文 斯高帕斯（Scopus）

• Natural Coumarin Derivative Esculetin Regulates Platelet Activation via Modulating NF-κB Signaling in Cyclic Nucleotide-Independent Manner

  Hsia, C. W., Shyu, K. G., Jayakumar, T., Hsia, C. H., Velusamy, M., Yang, C. H. & Sheu, J. R., 2019, 於: Natural Product Communications. 14, 12

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • esculetin 100%
  • Esculetin 96%
  • platelet activation 85%
  • Coumarins 83%
  • vasodilator agents 72%
  4 引文 斯高帕斯（Scopus）

• Neuroprotection by the traditional Chinese medicine, Tao-Hong-Si-Wu-Tang, against middle cerebral artery occlusion-induced cerebral ischemia in rats

  Sheu, J. R., Wu, C. J., Chen, J. T., Yen, T. L., Jayakumar, T., Chou, D. S. & Hsiao, G., 2011, 於: Evidence-based Complementary and Alternative Medicine. 2011, 803015.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • si-wu-tang 100%
  • Middle Cerebral Artery Infarction 54%
  • Chinese Traditional Medicine 52%
  • Neuroprotection 52%
  • Brain Ischemia 49%
  28 引文 斯高帕斯（Scopus）

• Neuroprotective effects of acetylsalicylic acid in middle cerebral artery occlusion-induced brain ischemia in rats: Suppression of iNOS, HIF-1α, TNF-α, and active caspase-3 expression

  Chang, T. H., Liu, C. L., Lin, K. H., Lin, M. N., Hsiao, G. & Sheu, J. R., 10月 2008, 於: Pharmaceutical Biology. 46, 10-11, p. 793-799 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Acetylsalicylic Acid 100%
  • Neuroprotective 97%
  • Middle Cerebral Artery Infarction 84%
  • Neuroprotective Agents 77%
  • Brain Ischemia 75%
  2 引文 斯高帕斯（Scopus）

• Neuroprotective effects of PMC, a potent α-tocopherol derivative, in brain ischemia-reperfusion: Reduced neutrophil activation and anti-oxidant actions

  Hsiao, G., Lee, J. J., Chen, Y. C., Lin, J. H., Shen, M. Y., Lin, K. H., Chou, D. S. & Sheu, J. R., 3月 1 2007, 於: Biochemical Pharmacology. 73, 5, p. 682-693 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Nitrotyrosine 100%
  • Tocopherols 83%
  • Neuroprotective 80%
  • Neutrophil Activation 79%
  • Middle Cerebral Artery Infarction 69%
  18 引文 斯高帕斯（Scopus）

• Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (humulus lupulus), in ischemic stroke of rats

  Yen, T. L., Hsu, C. K., Lu, W-J., Hsieh, C., Hsiao, G., Chou, D-S., Wu, G-J. & Sheu, J-R., 2月 29 2012, 於: Journal of Agricultural and Food Chemistry. 60, 8, p. 1937-1944 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • xanthohumol 100%
  • Xanthohumol 99%
  • Humulus lupulus 81%
  • Humulus 81%
  • neuroprotective effect 79%
  74 引文 斯高帕斯（Scopus）

• Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats

  Chang, Y., Hsieh, C. Y., Peng, Z. A., Yen, T. L., Hsiao, G., Chou, D. S., Chen, C. M. & Sheu, J. R., 2009, 於: Journal of Biomedical Science. 16, 1, 9.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Puerarin 100%
  • puerarin 99%
  • Brain Infarction 84%
  • Neuroprotective 83%
  • Middle Cerebral Artery Infarction 72%
  110 引文 斯高帕斯（Scopus）

• Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-κB repressing factor

  Ho, S. C., Lee, K. Y., Chan, Y. F., Kuo, L. W., Ito, K., Adcock, I. M., Chen, B. C., Sheu, J. R., Lin, C. H. & Kuo, H. P., 7月 1 2009, 於: Journal of Immunology. 183, 1, p. 411-420 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Leukocyte Elastase 100%
  • Interleukin-8 74%
  • Smooth Muscle Myocytes 68%
  • Smooth Muscle 15%
  • Gene Targeting 10%
  23 引文 斯高帕斯（Scopus）

• New therapeutic agent against arterial thrombosis: An iridium(III)-derived organometallic compound

  Hsia, C. W., Velusamy, M., Tsao, J. T., Hsia, C. H., Chou, D. S., Jayakumar, T., Lee, L. W., Li, J. Y. & Sheu, J. R., 12月 5 2017, 於: International Journal of Molecular Sciences. 18, 12, 2616.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Organometallic Compounds 100%
  • Iridium 84%
  • organometallic compounds 82%
  • thrombosis 81%
  • Organometallics 79%
  5 引文 斯高帕斯（Scopus）

• New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury

  Lu, W-J., Lin, K-H., Tseng, M-F., Yuan, K-C., Huang, H-C., Sheu, J-R. & Chen, R-J., 3月 1 2019, 於: Journal of Cellular and Molecular Medicine. 23, 3, p. 1723-1734 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • beta-thujaplicin 100%
  • Hemorrhagic Shock 64%
  • Liver 27%
  • Wounds and Injuries 26%
  • Resuscitation 21%
  2 引文 斯高帕斯（Scopus）

• Nobiletin, a citrus flavonoid, activates Vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms

  Jayakumar, T., Lin, K. C., Lu, W-J., Lin, C. Y., Pitchairaj, G., Li, J. Y. & Sheu, J-R., 1月 1 2017, 於: International Journal of Molecular Medicine. 39, 1, p. 174-182 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • nobiletin 100%
  • vasodilator-stimulated phosphoprotein 92%
  • Citrus 80%
  • Flavonoids 60%
  • Nucleotides 48%
  13 引文 斯高帕斯（Scopus）

• Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways

  Lien, L. M., Wang, M. J., Chen, R. J., Chiu, H. C., Wu, J. L., Shen, M. Y., Chou, D. S., Sheu, J. R., Lin, K. H. & Lu, W-J., 2月 1 2016, 於: Phytotherapy Research. 30, 2, p. 214-221 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • nobiletin 100%
  • flavone 85%
  • Glioma 55%
  • Cell Movement 49%
  • Cell Cycle 47%
  50 引文 斯高帕斯（Scopus）

• Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen–integrin α_{II b}β₃ binding in human platelets

  Hsia, C. H., Lu, W. J., Lin, K. H., Chou, D. S., Geraldine, P., Jayakuma, T., Chang, N. C. & Sheu, J. R., 4月 1 2018, 於: Journal of Cellular and Molecular Medicine. 22, 4, p. 2142-2152 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • norcantharidin 100%
  • Blood Platelets 44%
  • Integrins 30%
  • Fibrinogen 23%
  • Clot Retraction 12%
  7 引文 斯高帕斯（Scopus）

• Novel bioactivity of ellagic acid in inhibiting human platelet activation

  Chang, Y., Chen, W. F., Lin, K. H., Hsieh, C. Y., Chou, D. S., Lin, L. J., Sheu, J. R. & Chang, C. C., 2013, 於: Evidence-based Complementary and Alternative Medicine. 2013, 595128.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Ellagic Acid 100%
  • Platelet Activation 75%
  • Platelet Aggregation 45%
  • Protein Kinase C 32%
  • Type C Phospholipases 25%
  20 引文 斯高帕斯（Scopus）

• Novel drugs development for cardio-/cerebrovascular diseases

  Sheu, J. R., Thomas, P. A. & Cheng, J. T., 2014, 於: BioMed Research International. 2014, 467936.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation

  Shyu, K. G., Velusamy, M., Hsia, C. W., Yang, C. H., Hsia, C. H., Chou, D. S., Jayakumar, T., Sheu, J. R. & Li, J. Y., 5月 1 2018, 於: International Journal of Molecular Medicine. 41, 5, p. 2589-2600 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Organometallic Compounds 100%
  • Iridium 84%
  • Platelet Activation 57%
  • Platelet Aggregation 17%
  • Phospholipases 10%
  6 引文 斯高帕斯（Scopus）

• Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism

  Yen, T. L., Wu, M. P., Chung, C. L., Yang, W. B., Jayakumar, T., Geraldine, P., Chou, C. M., Chang, C. Y., Lu, W-J. & Sheu, J. R., 2月 17 2016, 於: Journal of Biomedical Science. 23, 1, 26.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • benzimidazole 100%
  • Anticoagulant Agent 89%
  • Thromboembolism 78%
  • Oligosaccharides 77%
  • Platelet Aggregation 70%
  4 引文 斯高帕斯（Scopus）

• Novel therapeutic agent against platelet activation in vitro and arterial thrombosis in vivo by morin hydrate

  Hsia, C. W., Wu, M. P., Velusamy, M., Hsia, C. H., Chou, D. S., Tsai, C. L., Hsu, C. Y., Jayakumar, T., Chung, C. L. & Sheu, J. R., 8月 13 2018, 於: International Journal of Molecular Sciences. 19, 8, 2386.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • morin 100%
  • thrombosis 95%
  • Morin 87%
  • Platelets 79%
  • hydrates 72%
  9 引文 斯高帕斯（Scopus）

• Nuclear-targeted inhibition of NF-κB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells

  Chou, Y. C., Sheu, J. R., Chung, C. L., Chen, C. Y., Lin, F. L., Hsu, M. J., Kuo, Y. H. & Hsiao, G., 3月 2010, 於: Chemico-Biological Interactions. 184, 3, p. 403-412 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • N-2-(4-bromophenyl) ethyl caffeamide 100%
  • Matrix Metalloproteinase 9 43%
  • Antiinflammatory 39%
  • Ethyl 29%
  • Protein 16%
  64 引文 斯高帕斯（Scopus）

• Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats

  Lee, Y. M., Cheng, P. Y., Hong, S. F., Chen, S. Y., Lam, K. K., Sheu, J. R. & Yen, M. H., 7月 1 2005, 於: Free Radical Biology and Medicine. 39, 1, p. 108-117 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Heme Oxygenase-1 100%
  • Oxidative Stress 84%
  • Heme 78%
  • Nitric Oxide Synthase Type II 67%
  • Blood Vessels 50%
  34 引文 斯高帕斯（Scopus）